Conquering Diseases

Study Of The Long Term Safety Of Ocrelizumab Treatment For People With Multiple Sclerosis (Ms)

Description

Seeking women and men who have started ocrelizumab treatment for their Multiple Sclerosis (MS) within the past month or people whose MS is being being treated with therapies other than ocrelizumab for a study looking at the incidence of cancer in the future.

Overview

We are studying whether people who are being treated with ocrelizumab for their Multiple Sclerosis (MS) are more or less likely to be diagnosed with cancer in the future by periodically looking at their medical records. We will compare the medical records of people getting ocrelizumab treatment with people whose MS is being treated with other therapies.

What we're hoping for

Evaluate the long-term safety of the drug ocrelizumab for Multiple Sclerosis by reviewing medical records periodically for breast cancer diagnoses

Additional Information

ClinicalTrials.gov Identifier: Not Available

 Principal Investigator

Roberto  Bomprezzi, MD, PhD

UMass Memorial Health Care

 Study Contact

Melissa  Adams

508-856-4676

melissa.adams@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989